NASDAQ:BBOT | Free Cash Flow | BridgeBio Oncology Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2024-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$35.92M$24,000.00-$35.94M
2025-12-31-$42.23M$73,000.00-$42.31M
2025-03-31-$19.6M$162,000.00-$19.76M
2024-12-31-$15.04M$10,000.00-$15.05M
2024-03-31-$617,999.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$113.89M$606,000.00-$114.5M
2024-12-31-$55.03M$49,000.00-$55.08M